Abstract

The invention relates to compounds of Formula I, wherein R1, R2, and R3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from olanzapine. The invention also relates to conjugates of an olanzapine hapten and a protein.


Claims
Download PDF
Document Preview
Document History
  • Publication: Apr 5, 2016
  • Application: Aug 20, 2013
    US US 201313970653 A
  • Priority: Aug 20, 2013
    US US 201313970653 A
  • Priority: Aug 21, 2012
    US US 201261691454 P

Sign in to the Lens